Stock Research: AxoGen

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

AxoGen

NasdaqCM:AXGN US05463X1063
46
  • Value
    24
  • Growth
    95
  • Safety
    Safety
    20
  • Combined
    43
  • Sentiment
    61
  • 360° View
    360° View
    46
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

Axogen, Inc. focuses on technologies for peripheral nerve regeneration and repair, offering repair solutions for surgeons and healthcare providers. It operates in the medical devices industry. Axogen operates in the United States. In the last fiscal year, the company had 451 employees, a market cap of $537 million, profits of $142 million, and revenue of $187 million.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 46 (better than 46% compared with alternatives), overall professional sentiment and financial characteristics for the stock AxoGen are below the industry average. The 360° View is based on consolidating four consolidated indicators, with half of the metrics below and half above average for AxoGen. The consolidated Growth Rank has a good rank of 95, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. This means that growth is higher than for 95% of competitors in the same industry. The consolidated Sentiment Rank also has a good rank of 61, which means that professional investors are more optimistic about the stock than for 61% of alternative investment opportunities. But the consolidated Value Rank has a less desirable rank of 20, which means that the share price of AxoGen is on the higher side compared with typical size in indicators such as revenues, profits, and invested capital. This means the stock price is higher than for 80% of alternative stocks in the same industry. Finally, the consolidated Safety Rank has a riskier rank of 24, which means that the company has a financing structure that is riskier than those of 76% comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. ...read more

more
Index
NASDAQ
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 21-Aug-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Value
Identifies how good a value the stock is.
Good Value Expensive
Growth
Shows a company's growth potential.
High Growth Tough Times
Safety
Safety
Assesses how financially secure a company is.
Well-Financed High Leverage
Combined
Consolidated view across Value, Growth, and Safety.
Good Tread Carefully
Sentiment
Shows what the market thinks of a stock.
Positive Sentiment Skepticism
360° View
360° View
Holistic stock analysis: all key non-/financial metrics
Good Watch Out

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
20 31 64 63
Growth
95 93 51 25
Safety
Safety
24 7 16 64
Sentiment
61 74 49 68
360° View
360° View
46 51 34 67
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
88 87 92 56
Opinions Change
82 75 50 50
Pro Holdings
n/a 47 26 74
Market Pulse
62 31 34 37
Sentiment
61 74 49 68
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
20 31 64 63
Growth
95 93 51 25
Safety Safety
24 7 16 64
Combined
43 40 31 48
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
22 13 26 26
Price vs. Earnings (P/E)
37 41 75 79
Price vs. Book (P/B)
29 25 59 66
Dividend Yield
1 1 1 1
Value
20 31 64 63
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
84 70 57 53
Profit Growth
96 98 86 39
Capital Growth
47 51 61 63
Stock Returns
83 97 21 11
Growth
95 93 51 25
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
58 46 40 52
Refinancing
31 30 61 77
Liquidity
37 37 14 20
Safety Safety
24 7 16 64

Similar Stocks

Discover high‑ranked alternatives to AxoGen and broaden your portfolio horizons.

Micron

NasdaqGS:MU
Country: USA
Industry: Semiconductors
Size: X-Large
Full Stock Analysis

Meta

NasdaqGS:FB
Country: USA
Industry: Interactive Media & Services
Size: XX-Large
Full Stock Analysis

Alphabet

NasdaqGS:GOOG.L
Country: USA
Industry: Interactive Media & Services
Size: XX-Large
Full Stock Analysis

Lithia Motors

NYSE:LAD
Country: USA
Industry: Automotive Retail
Size: X-Large
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.